Klin Farmakol Farm. 2016;30(3):18-20 | DOI: 10.36290/far.2016.024

Colloid silver and its biological activity

Renata Večeřová
Ústav mikrobiologie LF UP v Olomouci

The theoretical part of this article summarizes the antimicrobial potential of silver, including well-known historical facts, and its application in the form of nanoparticles within colloidal systems or as a part of nanocomposites. The outcomes of biological activity of colloidal silver tested at the Faculty of Medicine and Dentistry and Faculty of Science, Palacky University Olomouc, are also summarized in this article. The tests undertaken were focused on silver nanoparticles and their antibacterial and antifungal activity, cytotoxicity and synergic effect with selected antibiotics, and the development and testing of nanocomposites with possible medical application.

Keywords: colloid silver, silver nanoparticles, antimicrobial activity

Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Večeřová R. Colloid silver and its biological activity. Klin Farmakol Farm. 2016;30(3):18-20. doi: 10.36290/far.2016.024.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 2013; 11: 297-308. Go to original source... Go to PubMed...
    2. Alexander JW. History of medical use of silver. Surg Infect 2009; 10: 289-292. Go to original source... Go to PubMed...
    3. Mijnendonckx K, Leys N, Mahillon J, et al. Antimicrobial silver: uses, toxicity and potential for resistence. Biometals 2013; 26: 609-621. Go to original source... Go to PubMed...
    4. Filipová Z, Kukutschková J, Mašláň M. Rizika nanomateriálů. 1st ed. Univerzita Palackého v Olomouci; 2012.
    5. Panáček A, Kvítek L, Prucek R, et al. Silver colloid nanoparticles: Synthesis, characterization, and their antibacterial aktivity. J Phys Chem B 2006; 110: 16248-16253. Go to original source... Go to PubMed...
    6. Wong KKY, Liu XL. Silver nanoparticles-the real "silver bullet" in clinical medicine? Med Chem Comm 2010; 1: 125-131. Go to original source...
    7. Likus W, Bajor G, Siemianowicz K. Nanosilver - does it have only one face? Acta biochimica polonica 2013; 60: 495-501. Go to original source... Go to PubMed...
    8. Sharma VK, Yngard RA, Lin Y. Silver nanoparticles: Green synthesis and their antimicrobial activities. Adv Colloid Interface Sci 2009; 145: 83-96. Go to original source...
    9. Franci G, Falanga A, Galdiero S, et al. Silver nanoparticles as potencial antibacterial agent. Molecules 2015; 20: 8856-8874. Go to original source... Go to PubMed...
    10. Kvítek L, Panáček A, Soukupová J, et al. Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs). J Phys Chem C 2008; 112: 5825-5834. Go to original source...
    11. Panáček A, Kolar M, Vecerova R, et al. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 2009; 30: 6333-6340. Go to original source... Go to PubMed...
    12. Moritz M, Geszke-Moritz M. The newest achievement in synthesis, immobilization and practical application of antibacterial nanoparticles. Chem Eng J 2013; 228: 596-613. Go to original source...
    13. Panáček A, Smékalová M, Kilianová M, et al. Strong and nonspecific synergistic antibacterial efficiency of antibiotics combined with silver nanoparticles at very low concentrations showing no cytotoxic effect. Molecules 2016; 21: 26. Go to original source...
    14. Panáček A, Smékalová M, Večeřová R, et al. Silver nanoparticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae. Colloids and Surfaces B: Biointerfaces 2016; 142: 392-399. Go to original source...
    15. Prucek R, Tucek J, Kilianova M, et al. The targeted antibacterial and antifungal properties of magnetic nanocomposite of iron oxide and silver nanoparticles. Biomaterials 2011; 32: 4704-4713. Go to original source...
    16. Panáček A, Balzerová A, Prucek R, et al. Preparation, characterization and antimicrobial efficiency of Ag/PDDA - diatomite nanocomposite. Colloid Surf B-Biointerfaces 2013; 110: 191-198. Go to original source...
    17. Panacek A, Kilianova M,Prucek R, et al. Preparation and in vitro bactericidal and fungicidal efficiency of NanoSilver/methylcellulose hydrogel. International Journal of Chemical, Nuclear, Metallurgical and Materials Engineering 2014; 8.
    18. Lara HH, Ayala-Nunez NV, Turrent LDI et al. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J Microbiol Biotechnol 2010; 26: 615-621. Go to original source...
    19. Li WR, Xie XB, Shi QS et al. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Biometals 2011; 24: 135-141. Go to original source... Go to PubMed...
    20. Morones JR, Elechiguerra JL, Camacho A, et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005; 16: 2346-2353. Go to original source... Go to PubMed...
    21. Baker C, Pradhan A, Pakstis L, et al. Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol 2005; 5: 244-249. Go to original source... Go to PubMed...
    22. Kvítek L, Vaníčková M, Panáček A, et al. Initial study on the toxicity of silver nanoparticles (NPs) against Paramecium caudatum. J Phys Chem C 2009; 113: 4296-4300. Go to original source...
    23. Krajewski S, Prucek R, Panáček A, et al. Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human blood. Acta Biomaterialia 2013; 9: 7460-7468. Go to original source... Go to PubMed...
    24. Antony JJ, Sivalingam P, Chen B. Toxicological effects of silver nanoparticles. Environ toxicol pharmacol 2015; 40: 729. Go to original source... Go to PubMed...
    25. Brown AN, Smith K, Samuels TA, et al. Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureus. Appl Environ Microbiol 2012; 78: 2768-2774. Go to original source...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.